Healthcare
Healthcare
Selected Sub Sectors
- Acute, Rehabilitation & Post-Acute Services
- Digital Health
- Healthcare Technology
- Medical Technology
- Outpatient Services
- Pharmacy
- Pharma Services
- Physicial- and Oral Health Services
- Stationary & Outpatient Care
We advise leading healthcare companies and investors across healthcare services, pharma services (CDMO, CROs), medical technology, diagnostics, and digital health. The sector is defined by strong demographic tailwinds, accelerating innovation cycles, and sustained capital deployment, alongside increasing complexity in regulation, pricing, and reimbursement. Our team brings deep sector knowledge and long-standing transaction experience, underpinned by a nuanced understanding of clinical development pathways, intellectual property frameworks, and global regulatory regimes.
We support clients across the full spectrum of strategic and financial transactions, including mid-cap M&A, public and private capital raises, strategic partnerships, and portfolio optimization. Our advisory approach integrates scientific and medical insight with rigorous financial analysis, enabling clients to navigate value inflection points, assess risk-adjusted growth opportunities, and execute transactions that align long-term innovation with shareholder value creation. Our vast domestic and international relationships network allows us to understand decision parameters and approach all relevant strategic and financial investors.